Fredag 29 Augusti | 22:07:05 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-11-05 08:00 Kvartalsrapport 2025-Q3
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-22 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2025-05-21 - Årsstämma
2025-05-21 - Kvartalsrapport 2025-Q1
2025-02-12 - Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2024-05-22 - Årsstämma
2024-05-22 - Kvartalsrapport 2024-Q1
2024-02-14 - Bokslutskommuniké 2023
2023-12-29 - Extra Bolagsstämma 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2023-05-17 - Årsstämma
2023-05-17 - Kvartalsrapport 2023-Q1
2023-02-14 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-09-27 - Extra Bolagsstämma 2022
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-15 - Bokslutskommuniké 2021
2021-11-09 - Kvartalsrapport 2021-Q3
2021-09-14 - Extra Bolagsstämma 2021
2021-08-17 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2021-05-20 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-16 - Bokslutskommuniké 2020
2020-11-11 - Kvartalsrapport 2020-Q3

Kontakt

Hanna Sjöström

VD, Neola Medical
E-post: hanna.sjostrom@neolamedical.com

2025-08-27 11:30:00

How do you lead a publicly listed medtech company with a heart for patient care and eyes set on the U.S. market? In a new Spotlight interview with PRO TEMPORE, Hanna Sjöström, CEO of Neola Medical, shares her career journey, perspectives on leadership in times of change, and why she believes in the powerful combination of technology and purpose.

With experience from global giants such as L’Oréal and Coca-Cola, as well as agile medtech start-ups, Hanna Sjöström has found her place at the intersection of innovation and societal impact. As CEO of Neola Medical, she leads a company developing technology to continuously monitor the lungs of preterm born babies, with the goal of enabling earlier detection of complications. In the interview, she talks about steering a listed company through capital raising, regulatory milestones, and international expansion.

Beyond Neola Medical, Hanna Sjöström serves on several boards within the Life Science sector and shares her insights on leadership, perseverance, and what fuels her energy outside of work.

Read the full interview in Swedish here: Pro Tempore Spotlight - Hanna Sjöström